Tudóstér: Berecz Roland publikációi

Magyari, F., Virga, I., Simon, Z., Miltényi, Z., Illés, A., Kósa, K., Ivánka, T., Berecz, R., Égerházi, A., Illés, Á.: Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary.
Support. Care Cancer. 30 (6), 5249-5258, 2022.

Kellermann, M., Berecz, R., Bereczki, D.: Does the severity of depressive symptoms after stroke affect long-term survival? An 18-year follow-up.
PLoS One. 13 (12), 1-11, 2018.

Cosh, S., Zenter, N., Ay, E., Loos, S., Slade, M., De Rosa, C., Luciano, M., Berecz, R., Glaub, T., Munk-Jørgensen, P., Krogsgaard Bording, M., Rössler, W., Kawohl, W., Puschner, B.: Clinical Decision Making and Mental Health Service Use Among Persons With Severe Mental Illness Across Europe.
Psychiatr. Serv. 68 (9), 970-974, 2017.

Magyari, F., Kósa, K., Berecz, R., Illés, A., Miltényi, Z., Simon, Z., Illés, Á.: Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
Health Qual. Life Outcomes. 15 (1), 1-9, 2017.

Morvai, S., Nagy, A., Bálint-Szöllősi, A., Móré, E., Berecz, R., Frecska, E.: Ketamin alkalmazása súlyos, terápiarezisztens depressziós beteg esetében.
Ideggyógy. Szle. 69 (11-12), 421-425, 2016.

Magyari, F., Miltényi, Z., Simon, Z., Kósa, K., Berecz, R., Illés, Á.: Prognostic value of clinical, treatment and socio-demographic results of psychological distress among Hodgkin Lymphoma survivors in Hungary.
Haematologica. 101 71, 2016.

Morvai, S., Nagy, A., Kovács, A., Móré, E., Berecz, R., Frecska, E.: Unanswered questions in the transcranial magnetic stimulation treatment of patients with depression.
Ideggyogy. Szle. 69 (1-2), 4-11, 2016.

Balogh, N., Égerházi, A., Berecz, R.: Neurocognitive changes in patients with schizophrenia during relapse and early remission.
Eur. J. Psychiat. 29 (3), 199-209, 2015.

Balogh, N., Égerházi, A., Berecz, R., Csukly, G.: Investigating the state-like and trait-like characters of social cognition in schizophrenia: A short term follow-up study.
Schizophr. Res. 159 499-505, 2014.

Égerházi, A., Balla, P., Ritzl, A., Varga, Z., Frecska, E., Berecz, R.: Automated Neuropsychological Test Battery in depression - preliminary data.
Neuropsychopharmacologia Hung. 15 (1), 5-11, 2013.

Égerházi, A., Glaub, T., Balla, P., Berecz, R., Degrell, I.: P300 enyhe kognitív zavarban és demenciában = P300 in mild cognitive impairment and in dementia.
Psychiatr. Hung. 23 (5), 349-357, 2008.

Égerházi, A., Berecz, R., Bartók, E., Degrell, I.: Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
Prog. Neuropsychopharmacol. Biol. Psychiatry. 31 (3), 746-751, 2007.

Emri, M., Glaub, T., Berecz, R., Lengyel, Z., Mikecz, P., Repa, I., Bartók, E., Degrell, I., Trón, L.: Brain blood flow changes measured by positron emission tomography during an auditory cognitive task in healthy volunteers and in schizophrenic patients.
Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 30 (3), 516-520, 2006.

Dorado, P., Berecz, R., Penas-Lledo, E., Cáceres, M., LLerena, A.: Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs.
Curr. Drug Targets. 7 (12), 1671-1680, 2006.

Bartók, E., Berecz, R., Glaub, T., Degrell, I.: Cognitive functions in prepsychotic patients.
Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 29 (4), 621-625, 2005.

Berecz, R., de la, R., Dorado, P., Fernández-Salguero, P., Dahl, M., LLerena, A.: Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
Eur. J. Clin. Pharmacol. 59 (1), 45-50, 2003.

Emri, M., Bogner, P., Balkay, L., Tóth, Á., Kisely, M., Weisz, J., Ádám, G., Glaub, T., Berecz, R., Repa, I.: [15 O]-butanol PET-vizsgálatok térbeli standardizálása szegmentált, T1-súlyozott MRI-felvételek segítségével.
Orv. Hetil. 143 (21), 1249-1251, 2002.

Degrell, I., Berecz, R., Glaub, T., Lengyel, Z., Égerházi, A., Szakáll, S., Trón, L.: A pozitronemissziós tomográfia pszichiátriai alkalmazása = Use of positron emission tomography in psychiatry.
Orv. Hetil. 143 (21), 1311-1314, 2002.

Glaub, T., Berecz, R., Lengyel, Z., Emri, M., Márián, T., Bartók, E., Trón, L., Degrell, I.: Auditoros eseményhez kötött potenciál és PET: lehetőseg a kognició folyamatának komplex megközelitésére.
Orv. Hetil. 143 (21), 1322-1324, 2002.

Berecz, R., LLerena, A., Rubia, A., Gómez, J., Kellermann, M., Dorado, P., Degrell, I.: Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients.
Pharmacopsychiatry. 35 (6), 231-234, 2002.

Berecz, R., Glaub, T., Kellermann, M., Rubia, A., LLerena, A., Degrell, I.: Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
Pharmacopsychiatry. 33 (1), 42-44, 2000.

Nagy, E., Berecz, R., Kellermann, M., Degrell, I., Nagy, E., Dinya, Z.: The measurement of haloperidol and reduced haloperidol in plasma of psychiatric patients and their relationship to the administered.
Advances in chromatography and electrophoresis 1 151-159, 1998.

Berecz, R., Nagy, E., Kellermann, M., Degrell, I.: The measurement of the plasma levels of risperidone and its metabolite 9-hydroxyrisperidone in psychiatric patients.
Adv. Chrom. Electrop. 1 19-23, 1998.